Haley Laken

Haley Laken serves as the Chief Scientific Officer at Zenas BioPharma and holds a board member position at InCephalo. Additionally, Laken is a strategic advisor for Advise Connect Inspire, LLC, and previously held the position of Chief Operating Officer and strategic advisor at Tabby Therapeutics, where contributions included driving critical scientific experiments and securing funding. Previously, Laken worked as Chief Development Officer at Jounce Therapeutics, overseeing strategic assessments and program management, and held various leadership roles at TESARO, Rhythm Pharmaceuticals, and Pfizer, focusing on drug development and operations in metabolic disease, oncology, and immunotherapies. Laken holds a PhD in Human Genetics and Molecular Biology from The Johns Hopkins University and a BA in Biology from DePauw University.